SAR 80.0
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Operating Cash Flow | 45.37 Million | 27.32 Million | 13.95 Million | 38.12 Million | 32.98 Million |
Net Income | 36.99 Million | 35.39 Million | 30.92 Million | 39.1 Million | 31.4 Million |
Depreciation & Amortization | 1.14 Million | 741.01 Thousand | 866.77 Thousand | 1.29 Million | 2.1 Million |
Deferred income taxes | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - |
Change in working capital | -3.51 Million | -13.9 Million | -18.28 Million | -7.74 Million | -4.2 Million |
Other non-cash items | 10.73 Million | 5.09 Million | 452.25 Thousand | 19.94 Million | 20.76 Million |
Investing Cash Flow | -2.47 Million | -175.33 Thousand | -209.07 Thousand | -268 Thousand | -130.65 Thousand |
Investments in PPE | -2.47 Million | -175.33 Thousand | -209.07 Thousand | -268 Thousand | -130.65 Thousand |
Acquisitions | - | - | - | - | - |
Investment purchases | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - |
Financing Cash Flow | -19.77 Million | -28.44 Million | -14.31 Million | -33.37 Million | -21.91 Million |
Debt repayment | -6.97 Million | -408.74 Million | -276.19 Million | -431.23 Thousand | -6.19 Million |
Dividends payments | -26.1 Million | -10 Million | -19.98 Million | -31.74 Million | -25.92 Million |
Common Stock Repurchased | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - |
Other Financing Activities | 6.97 Million | 390.29 Million | 281.86 Million | -547.31 Thousand | -111.87 Thousand |
Accounts receivables | -404.9 Thousand | -23.84 Million | -21 Million | -10.73 Million | -13.3 Million |
Accounts payables | 1.21 Million | 9.93 Million | 2.72 Million | -1.13 Million | 434.68 Thousand |
Inventory | - | 2.36 Million | 4.11 Million | - | - |
Other working capital | -4.32 Million | -2.36 Million | -4.11 Million | 4.12 Million | 8.65 Million |
Cash at beginning of period | 17.63 Million | 9.98 Million | 10.55 Million | 18.85 Million | 7.9 Million |
Cash at end of period | 40.97 Million | 8.69 Million | 9.98 Million | 21.8 Million | 18.85 Million |
Capital Expenditure | -2.47 Million | -175.33 Thousand | -209.07 Thousand | -268 Thousand | -130.65 Thousand |
Effect of forex changes on cash | 224.06 Thousand | 212.49 Thousand | - | -1.52 Million | -148.2 Thousand |
Net cash flow / Change in cash | 23.34 Million | -1.29 Million | -566.95 Thousand | 2.95 Million | 10.94 Million |
Free Cash Flow | 42.89 Million | 27.14 Million | 13.74 Million | 37.85 Million | 32.85 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 9.86 Million | 9.86 Million | 36.99 Million | 20.21 Million | 10 Million | 16.77 Million |
Depreciation & Amortization | 316.01 Thousand | 316.01 Thousand | 1.14 Million | 596.86 Thousand | 298.43 Thousand | 552.26 Thousand |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -10.11 Million | -10.11 Million | -3.51 Million | 9.03 Million | 6.85 Million | -12.54 Million |
Other non-cash items | 1.42 Million | 1.42 Million | 10.73 Million | 4.33 Million | 1.31 Million | 7.89 Million |
Investing Cash Flow | -58.63 Thousand | -58.63 Thousand | -2.47 Million | -250.06 Thousand | -125.03 Thousand | -2.22 Million |
Investments in PPE | -58.63 Thousand | -58.63 Thousand | -2.47 Million | -250.06 Thousand | -125.03 Thousand | -2.22 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | -7.98 Million | -7.98 Million | -19.77 Million | -16.46 Million | -7.82 Million | -3.31 Million |
Debt repayment | -1.3 Million | - | -6.97 Million | -4.65 Million | - | -11.62 Million |
Dividends payments | -14.1 Million | -7.05 Million | -26.1 Million | -12 Million | -6 Million | -14.1 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -936.79 Thousand | -936.79 Thousand | 6.97 Million | -1.82 Million | -1.82 Million | 4.99 Million |
Accounts receivables | -7.52 Million | -7.52 Million | -404.9 Thousand | 7.24 Million | 3.62 Million | -7.65 Million |
Accounts payables | 393.97 Thousand | - | 1.21 Million | -2.47 Million | - | 3.68 Million |
Inventory | - | - | - | -1.63 Million | - | - |
Other working capital | -2.59 Million | -2.59 Million | -4.32 Million | 5.89 Million | 3.23 Million | -8.58 Million |
Cash at beginning of period | 40.97 Million | - | 17.63 Million | 10.64 Million | - | 8.69 Million |
Cash at end of period | 27.86 Million | -6.55 Million | 40.97 Million | 40.97 Million | 10.63 Million | 10.64 Million |
Capital Expenditure | -58.63 Thousand | -58.63 Thousand | -2.47 Million | -250.06 Thousand | -125.03 Thousand | -2.22 Million |
Effect of forex changes on cash | -3740.00 | -3740.00 | 224.06 Thousand | 111.32 Thousand | 111.32 Thousand | 709.00 |
Net cash flow / Change in cash | -13.11 Million | -6.55 Million | 23.34 Million | 30.33 Million | 10.63 Million | 1.95 Million |
Free Cash Flow | 1.43 Million | 1.43 Million | 42.89 Million | 37.51 Million | 18.35 Million | 5.37 Million |
600499
GSS
BOA
300135
0687
EUCA4